Biostate AI closes $12M to bring the Netflix model to molecular diagnostics
Posted:
Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M Series A funding round, led by Accel. The company’s immediate focus is revolutionizing RNAseq accessibility and developing clinically relevant predictive models.
A wave of British scientific breakthroughs is poised to transform how prostate cancer is found and treated.
Prostate cancer is the most common cancer in men across the UK, and the second most common cause of cancer deaths after lung cancer. …
Free live virtual Learna Open Day for healthcare professionals considering postgraduate study. See how online study works, view the platform live, and submit questions. Wed 11 Feb, 13:00 GMT.
Read more and register here.
Attendees
Sponsors and Exhibitors
Contact us